Literature DB >> 4718964

Bactericidal activity of metronidazole against Bacteroides fragilis.

J P Whelan, J H Hale.   

Abstract

Metronidazole was found to be active against Bacteroides fragilis strains isolated from human lesions. The minimal inhibitory concentrations (MIC) were from 0.16 to 2.5 mug/ml and the minimal bactericidal concentrations (MBC) were from 0.16 to 2.5 mug/ml; usually the MIC and MBC figures were equivalent. These levels are easily attainable in the serum following normal therapeutic doses. The drug is not toxic and side effects are rare and it would therefore seem highly suitable for treating Bacteroides infections and also may be considered prophylactically in certain situations that are described.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4718964      PMCID: PMC477766          DOI: 10.1136/jcp.26.6.393

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Combined agar diffusion and replica plating techniques in the study of antibacterial substances.

Authors:  S D ELEK; G R HILSON
Journal:  J Clin Pathol       Date:  1954-02       Impact factor: 3.411

2.  Metronidazole in amoebic dysentery and amoebic liver abscess.

Authors:  S J Powell; I MacLeod; A J Wilmot; R Elsdon-Dew
Journal:  Lancet       Date:  1966-12-17       Impact factor: 79.321

3.  Induction of in-vivo resistance of trichomonas vaginalis to nitrimidazine.

Authors:  F Benazet; L Guillaume
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

4.  Activity of metronidazole against experimental tetanus and gas gangrene.

Authors:  W A Freeman; J A McFadzean; J P Whelan
Journal:  J Appl Bacteriol       Date:  1968-12

Review 5.  Wound infection: etiology, prevention, and management, including selection of antibiotics.

Authors:  J C Todd
Journal:  Surg Clin North Am       Date:  1968-08       Impact factor: 2.741

6.  Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole.

Authors:  J A McFadzean; I M Pugh; S L Squires; J P Whelan
Journal:  Br J Vener Dis       Date:  1969-06

7.  Bacteroides pneumonias. Characteristics of cases with empyema.

Authors:  J R Tillotson; A M Lerner
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

8.  [The spectrum of antibacterial activity of metronidazole].

Authors:  M Füzi; Z Csukás
Journal:  Zentralbl Bakteriol Orig       Date:  1970

9.  The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro.

Authors:  H R Ingham; J B Selkon; A A Codd; J H Hale
Journal:  J Clin Pathol       Date:  1970-04       Impact factor: 3.411

10.  Trichomoniasis in a closed community: efficacy of metronidazole.

Authors:  E E Keighley
Journal:  Br Med J       Date:  1971-01-23
View more
  25 in total

1.  Letter: Metronidazole in treatment of empyema.

Authors:  B J Smith; J Wellingham
Journal:  Br Med J       Date:  1976-05-01

2.  A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

3.  In vitro effect of metronidazole and tinidazole on anaerobic bacteria.

Authors:  K Dornbusch; C E Nord
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

4.  Pharmacokinetics of metronidazole as determined by bioassay.

Authors:  E D Ralph; J T Clarke; R D Libke; R P Luthy; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

5.  Access of metronidazole into the chronically inflamed middle ear with reference to anaerobic bacterial infections.

Authors:  L Jokipii; P Karma; A M Jokipii
Journal:  Arch Otorhinolaryngol       Date:  1978-06-27

Review 6.  Bacterial synergy in pelvic inflammatory disease.

Authors:  I Brook
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

7.  Treatment of anaerobic infections with metronidazole.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

8.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

9.  Methods for testing antibiotic sensitivity of anaerobic bacteria.

Authors:  J A Garcĭa-Rodriguez; J E Garcĭa-Sánchez; J Prieto-Prieto
Journal:  Infection       Date:  1980       Impact factor: 3.553

10.  Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.

Authors:  I Brook; J C Coolbaugh; R I Walker; E Weiss
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.